Á lódáil...
Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma
BACKGROUND: The Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) is important to gauge clinical benefit in metastatic renal cell carcinoma (mRCC). OBJECTIVE: To estimate important difference (ID) in FKSI DRS scores that is considered to be meaningful w...
Na minha lista:
| Foilsithe in: | Value Health |
|---|---|
| Main Authors: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788639/ https://ncbi.nlm.nih.gov/pubmed/30502785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2018.04.1371 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|